To build upon our in vitro findings, we then examined samples from patients with HBV-HCC and publicly available scRNA-seq data obtained from liver biopsies of patients with CHB and functional cure to assess whether there was an association between N4BP1 mRNA expression in the liver and HBV reactivation status. Here, N4BP1 is linked to hepatocellular carcinoma.